166 related articles for article (PubMed ID: 16390782)
1. Cyclooxygenase-2 expression in endometrial polyps during menopause.
Maia H; Correia T; Freitas LA; Athayde C; Coutinho E
Gynecol Endocrinol; 2005 Dec; 21(6):336-9. PubMed ID: 16390782
[TBL] [Abstract][Full Text] [Related]
2. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
4. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle.
Maia H; Pimentel K; Silva TM; Freitas LA; Zausner B; Athayde C; Coutinho EM
Gynecol Endocrinol; 2006 Apr; 22(4):219-24. PubMed ID: 16723309
[TBL] [Abstract][Full Text] [Related]
5. The role of hormone replacement therapy in endometrial polyp formation.
Oguz S; Sargin A; Kelekci S; Aytan H; Tapisiz OL; Mollamahmutoglu L
Maturitas; 2005 Mar; 50(3):231-6. PubMed ID: 15734604
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis.
Tokyol C; Aktepe F; Dilek FH; Sahin O; Arioz DT
Int J Gynecol Pathol; 2009 Mar; 28(2):148-56. PubMed ID: 19188819
[TBL] [Abstract][Full Text] [Related]
7. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
[TBL] [Abstract][Full Text] [Related]
8. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
[TBL] [Abstract][Full Text] [Related]
9. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
Inceboz US; Nese N; Uyar Y; Ozcakir HT; Kurtul O; Baytur YB; Kandiloglu AR; Caglar H; Fraser IS
Gynecol Obstet Invest; 2006; 61(1):24-8. PubMed ID: 16141722
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
11. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?
Xuebing P; TinChiu L; Enlan X; Jing L; Xiaowu H
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):198-203. PubMed ID: 21726930
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
Gul A; Ugur M; Iskender C; Zulfikaroglu E; Ozaksit G
Arch Gynecol Obstet; 2010 Mar; 281(3):479-83. PubMed ID: 19506890
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
[No Abstract] [Full Text] [Related]
14. Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: comparison with postmenopausal polyps.
Altaner S; Gucer F; Tokatli F; Guresci S; Ozdemir C; Puyan FO; Kutlu K
Onkologie; 2006 Sep; 29(8-9):376-80. PubMed ID: 16974115
[TBL] [Abstract][Full Text] [Related]
15. The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index.
Belisário MS; Vassallo J; Andrade LA; Alvarenga M; Pinto GA; Monteiro IM
Maturitas; 2006 Jan; 53(1):114-8. PubMed ID: 15894442
[TBL] [Abstract][Full Text] [Related]
16. Ki-67, Bcl-2 and p53 expression in endometrial polyps and in the normal endometrium during the menstrual cycle.
Maia H; Maltez A; Studart E; Athayde C; Coutinho EM
BJOG; 2004 Nov; 111(11):1242-7. PubMed ID: 15521869
[TBL] [Abstract][Full Text] [Related]
17. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?
Antunes A; Andrade LA; Pinto GA; Leão R; Pinto-Neto AM; Costa-Paiva L
Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):264-72. PubMed ID: 23301386
[TBL] [Abstract][Full Text] [Related]
18. The expression of cyclooxygenase-2 and vascular endothelial growth factor in the endometrium during the peri-implantation period in women with and without polyps.
Xiao Y; Peng X; Ma N; Li TC; Xia E
Hum Fertil (Camb); 2014 Mar; 17(1):67-71. PubMed ID: 24471989
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
[TBL] [Abstract][Full Text] [Related]
20. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
Cohen I
Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
